| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/14/2002 | WO2002020769A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | WO2002020764A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020763A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020762A2 Tnf receptor-like molecules and uses thereof |
| 03/14/2002 | WO2002020757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | WO2002020736A2 Proteases |
| 03/14/2002 | WO2002020735A2 Enzymes having high temperature polymerase activity and methods of use thereof |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020718A2 Osteoclast-associated receptor |
| 03/14/2002 | WO2002020620A2 Monoclonal antibody against ovarian carcinoma |
| 03/14/2002 | WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 03/14/2002 | WO2002020617A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 03/14/2002 | WO2002020615A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 03/14/2002 | WO2002020563A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 03/14/2002 | WO2002020562A2 Family member of inhibitor of apoptosis proteins |
| 03/14/2002 | WO2002020560A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | WO2002020555A2 Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components |
| 03/14/2002 | WO2002020554A2 Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines |
| 03/14/2002 | WO2002020092A1 Use of serum response factor (srf) modulator for treating srf related diseases |
| 03/14/2002 | WO2002020056A2 Methods and compositions for producing a neurosalutary effect in a subject |
| 03/14/2002 | WO2002020039A2 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites |
| 03/14/2002 | WO2002020038A2 Method for down-regulating ige |
| 03/14/2002 | WO2002019960A2 Purification, characterization and use of protective antigenic structures against trypanosomes and related parasites |
| 03/14/2002 | WO2001090189A3 G-protein coupled receptor org3. |
| 03/14/2002 | WO2001081581A3 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 03/14/2002 | WO2001077147A3 New bromodomain protein |
| 03/14/2002 | WO2001070805A3 Soluble mast cell function associated antigen (mafa) pharmaceutical compositions and methods of making and using them |
| 03/14/2002 | WO2001062969A3 Estrogen receptor alpha variants and methods of detection thereof |
| 03/14/2002 | WO2001061007A3 Fibroblast growth factor-23 molecules and uses thereof |
| 03/14/2002 | WO2001059129A3 Mammalian secreted group iii phospholipase a2 |
| 03/14/2002 | WO2001059064A3 Nucleic acids, proteins, and antibodies |
| 03/14/2002 | WO2001058921A9 Methods and compositions for generating angiostatin |
| 03/14/2002 | WO2001057085A3 G-protein coupled receptors |
| 03/14/2002 | WO2001055392A3 Nuclear hormone receptors |
| 03/14/2002 | WO2001055358A3 Phosphodiesterases |
| 03/14/2002 | WO2001055312A3 Nucleic acids, proteins, and antibodies |
| 03/14/2002 | WO2001051512A3 Human and parasite orphan receptor proteins |
| 03/14/2002 | WO2001048162A3 Method for the production of vitamin a |
| 03/14/2002 | WO2001040472A3 Streptococcus pneumoniae antigens |
| 03/14/2002 | WO2001036684A3 Mammalian toxicological response markers |
| 03/14/2002 | WO2001023572A3 Polynucleotides and polypeptides encoded thereby |
| 03/14/2002 | WO2000056899A9 Dsp-2 dual-specificity map kinase phosphatase |
| 03/14/2002 | WO2000053742A9 Polynucleotides and proteins encoded thereby |
| 03/14/2002 | WO1997003998A9 Modulators of the function of fas receptors and other proteins |
| 03/14/2002 | US20020032323 Polynucleotide and polypeptide sequence information stored on computer readable media |
| 03/14/2002 | US20020032317 Adsorbing the protein to Protein A immobilized on a solid phase of silica or glass; washing the solid phase with a hydrophobic electrolyte solvent; and recovering the protein from the solid phase. |
| 03/14/2002 | US20020032315 Humanized; binds human VEGF with a Kd value of no more than about 1 x 10-8M; inhibits VEGF-induced proliferation of endothelial cells in vitro. |
| 03/14/2002 | US20020032313 Vascular endothelial cell growth factor antagonists |
| 03/14/2002 | US20020032312 Recombinant multispecific molecule comprising an anti-Fc receptor portion and an anti-target portion. |
| 03/14/2002 | US20020032307 Hepadnavirus pre-S protein fragments |
| 03/14/2002 | US20020032152 Anti-helicobacter vaccine complex |
| 03/14/2002 | US20020031806 Purified human erythropoietin receptor protein fragment and antibodies derived therefrom |
| 03/14/2002 | US20020031800 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | US20020031798 Antibody recognizing human 25-hydroxyvitamin D3-1a-hydroxylase |
| 03/14/2002 | US20020031797 Novel nucleic acid isolated from tetrahymena which codes for a triterpenoid cyclase, its production, and use |
| 03/14/2002 | US20020031793 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 03/14/2002 | US20020031792 Complexing with monoclonal antibodies |
| 03/14/2002 | US20020031784 Anti-apo-B-48 monoclonal antibody, hybridoma producing the same, and method for measuring apo-B-48 using the same |
| 03/14/2002 | US20020031781 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 03/14/2002 | US20020031761 Amino acid sequences for use in the detection and separation of preferential microorganism from samples |
| 03/14/2002 | US20020031528 Vaccines containing beta-hexosamine bind with antibodies and carriers |
| 03/14/2002 | US20020031517 Administering an inhibitor of GDF-8, or a related member of Transforming Growth Factor-beta superfamily of structurally-related growth factors |
| 03/14/2002 | US20020031516 Administering therapeutic formulation comprising polyclonal antibodies directed to tumor necrosis factor |
| 03/14/2002 | US20020031515 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 03/14/2002 | US20020031514 Method for induction of differentiation of osteoclasts |
| 03/14/2002 | US20020031513 Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals |
| 03/14/2002 | US20020031512 Inhibiting immunological activation of keratinocytes by administering molecule that binds to CD40 but does not activate CD40-expressing keratinocytes |
| 03/14/2002 | US20020031510 Contacting B7-positive cell with first soluble ligand which recognizes and binds B7 antigen, and contacting gp39-positive cell with second soluble ligand which recognizes and binds gp39 antigen; inhibiting rejection of transplanted tissues |
| 03/14/2002 | US20020031497 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 03/14/2002 | US20020031492 Providing a brain tumor sample, quantifying the expression of an interleukin-13 (IL-13) receptor in the sample; and correlating the quantity of expression of the IL-13 receptor with the tumor type or grade; prognosis |
| 03/14/2002 | US20020031491 Stem cell factor: composition claims |
| 03/14/2002 | DE10043227A1 Neuartiges entwicklungsbiologisches Gen Novel biological developmental gene |
| 03/14/2002 | CA2730627A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2422204A1 Human antibodies against pseudomonas aeruginosa lps derived from transgenic mice |
| 03/14/2002 | CA2422114A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | CA2421922A1 Proteases |
| 03/14/2002 | CA2421912A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2421842A1 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 03/14/2002 | CA2421783A1 Receptor in the edb fibronectin domain |
| 03/14/2002 | CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | CA2421374A1 Methods and compositions for diseases associated with amyloidosis |
| 03/14/2002 | CA2421274A1 Method for down-regulating ige |
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421251A1 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 03/14/2002 | CA2421248A1 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 03/14/2002 | CA2421218A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | CA2421199A1 Hiv regulatory and auxiliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | CA2421193A1 Hiv peptides, antigens, vaccine compositions,immunoassay kit and a method of detecting antibodies induced by hiv |
| 03/14/2002 | CA2421191A1 Methods and compositions for in vitro targeting |
| 03/14/2002 | CA2421187A1 Family member of inhibitor of apoptosis proteins |
| 03/14/2002 | CA2421155A1 Osteoclast-associated receptor |
| 03/14/2002 | CA2421075A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2421070A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 03/14/2002 | CA2421027A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2419975A1 Enzymes having high temperature polymerase activity and methods of use thereof |
| 03/14/2002 | CA2419456A1 Methods and compositions for producing a neurosalutary effect in a subject |